MiMedx Group, Inc. (MDXG)
NASDAQ·Healthcare·Biotechnology
$3.26
-1.51%
Mkt Cap $478.64M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (8 analysts)
$7.67
Range $7.00 – $8.00
Implied Upside
+135.3%
Consensus $7.67 vs current $3.26
NASDAQ·Healthcare·Biotechnology
$3.26
-1.51%
Mkt Cap $478.64M
Buy
2
Hold
0
Sell
0
Price Target (8 analysts)
$7.67
Range $7.00 – $8.00
+135.3%
Consensus $7.67 vs current $3.26